- +110.2% price growth over the last year
- Low bankruptcy risk (Altman Z-Score: 6.79)
- Bullish trend confirmed on both short and long timeframes
Nurix Therapeutics, Inc. stock price ended at $23.21 on Friday, after losing 1.57%
(Updated on Jul 31, 2026)
The Nurix Therapeutics, Inc. stock price fell by -1.57% on the last day (Friday, 31st Jul 2026) from $23.58 to $23.21. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 2.60% from a day low at $23.08 to a day high of $23.68. The price has been going up and down for this period, and there has been a 0.39% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -450 thousand shares and in total, 752 thousand shares were bought and sold for approximately $17.45 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 59.91% during the next 3 months and, with a 90% probability hold a price between $33.63 and $43.79 at the end of this 3-month period.
NRIX Signals & Forecast
The Nurix Therapeutics, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $23.58. On a fall, the stock will find some support from the long-term average at approximately $22.06. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -5.99%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Nurix Therapeutics, Inc. stock
Nurix Therapeutics, Inc. finds support from accumulated volume at $22.90 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.600 (2.60%) between high and low. For the last week, the stock has had daily average volatility of 4.82%.
Our recommended stop-loss: $22.19 (-4.38%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 16 days ago.)
Trading Expectations (NRIX) For The Upcoming Trading Day Of Monday 3rd
For the upcoming trading day on Monday, 3rd we expect Nurix Therapeutics, Inc. to open at $23.32, and during the day (based on 14 day Average True Range), to move between $22.62 and $23.80, which gives a possible trading interval of +/-$1.18 (+/-5.23%) up or down from last closing price. If Nurix Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 5.23% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $22.90 (1.34%) than the resistance at $23.60 (1.68%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Nurix Therapeutics, Inc. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Nurix Therapeutics, Inc. stock to perform well in the short-term.
Current score:
2.078
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 3, 2026 - $23.32 ( 0.488%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
NRIX Performance
Trading levels for NRIX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 23.92 | 3.07% |
| R2 | 23.69 | 2.09% |
| R1 | 23.55 | 1.48% |
| Price | 23.21 | |
| S1 | 23.09 | -0.499% |
| S2 | 22.95 | -1.11% |
| S3 | 22.72 | -2.10% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 24.26 | 4.52% |
| R2 | 23.85 | 2.76% |
| R1 | 23.60 | 1.68% |
| Price | 23.21 | |
| S1 | 22.90 | -1.34% |
| S2 | 22.46 | -3.23% |
| S3 | 17.55 | -24.39% |
FAQ
Click here for our free guide on how to buy Nurix Therapeutics, Inc. Stock.
Buy NRIX